Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. HLB Co., Ltd.
  6. Summary
    A028300   KR7028300002

HLB CO., LTD.

(A028300)
 SummaryChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Korea Stock Exchange
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
65300 61100 63000 67000 65800 Last
1610116 2313855 1534403 2875394 1801716 Volume
+0.62% -6.43% +3.11% +6.35% -1.79% Change
Estimated financial data (e)
Sales 2019 38 421 M 32,5 M 32,5 M
Net income 2019 -44 386 M -37,6 M -37,6 M
Net Debt 2019 35 930 M 30,4 M 30,4 M
P/E ratio 2019 -106x
Yield 2019 -
Sales 2020 56 177 M 47,5 M 47,5 M
Net income 2020 -80 093 M -67,8 M -67,8 M
Net cash position 2020 170 B 144 M 144 M
P/E ratio 2020 -63,1x
Yield 2020 -
Capitalization 7 006 B 5 939 M 5 927 M
EV / Sales 2019 128x
EV / Sales 2020 84,0x
Nbr of Employees 93
Free-Float 87,1%
More Financials
Company
HLB Inc is a Korea-based company mainly engaged in the manufacture and sale of lifeboats and electrical instruments. The Company engineers and manufactures electrical instruments, and provides related installment services for sewage treatment plants, automatic control systems and others. In addition, it provides lifeboats such as totally enclosed lifeboats, free-fall lifeboats and others, glass fiber reinforced... 
More about the company
All news about HLB CO., LTD.
2020HLB Co., Ltd. announced that it has received KRW 29.00517165 billion in fundi..
CI
2020HLB Life Science Co., Ltd. cancelled the acquisition of 14% stake in HLB Co.,..
CI
2020HLB Co., Ltd. completed the acquisition of remaining 99.99% stake in HLB USA..
CI
2020HLB Co., Ltd. announced that it expects to receive KRW 29.00517165 billion in..
CI
2020HLB USA, Inc. cancelled to acquire 6.62% stake in HLB Co., Ltd..
CI
2020Immunomic Therapeutics, Inc. and HLB Co., LTD. Intends to Establish an Asian ..
CI
2020HLB Co., Ltd. agreed to acquire an additional 46.4% stake in Immunomic Therap..
CI
2020Immunomic Therapeutics, Inc. announced that it has received $10 million in fu..
CI
2019HLB Co., Ltd. announced that it has received KRW 40 billion in funding
CI
2019HLB Co., Ltd. announced that it expects to receive KRW 40 billion in funding
CI
2019HLB Co., Ltd. announced that it has received KRW 187.907176644 billion in fun..
CI
2019HLB Life Science Co., Ltd. agreed to acquire 14% stake in HLB Co., Ltd. from ..
CI
2019HLB Co., Ltd. agreed to acquire remaining 99.99% stake in HLB USA, Inc. for a..
CI
2019HLB USA, Inc.. agreed to acquire 6.62% stake in HLB Co., Ltd. for approximate..
CI
2019HLB Co., Ltd. announced that it has received KRW 20 billion in funding from O..
CI
More news
News in other languages on HLB CO., LTD.

- No features available -

More news
Chart HLB CO., LTD.
Duration : Period :
HLB Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HLB CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Managers and Directors
Yang-Gon Jin Chairman & Chief Executive Officer
Sung-Je Kim Independent Director
Jin-Gook Park Independent Director
Kyu-Jun Choi Independent Director
Jae-Chul Sim Independent Director
Sector and Competitors
1st jan.Capi. (M$)
HLB CO., LTD.42.27%5 939
YETI HOLDINGS, INC.44.63%8 662
BRP INC.43.89%7 657
BRUNSWICK CORPORATION27.74%7 551
POLARIS INC.25.62%7 252
THOR INDUSTRIES, INC.18.32%6 085